RPRX

Q: What is the price of Royalty Pharma (RPRX) today?

The price of Royalty Pharma (RPRX) today is US$ 36,01, with a variation of 34.65% compared to the last year. The price of Royalty Pharma (RPRX) started the year trading around US$ 25,51 and today it is at US$ 36,01. Follow the real-time price chart, the historical price of Royalty Pharma (RPRX), and stock data from Ibovespa and international markets.

Q: When does Royalty Pharma (RPRX) pay dividends?

Royalty Pharma (RPRX) distributed dividends in the last year,in the months of March, June and September totaling US$ 0,66. The Dividend Yield for the last 12 months is 2,41%.

Q: Royalty Pharma (RPRX) is it worth it?

Currently, Royalty Pharma (RPRX) is priced at US$ 36,01, with a P/E of 30,17%, representing a deviation of 17,90% from its historical average P/E. In the last year, the stock showed a variation of 34.65% in its price and distributed US$ 0,66 in dividends, resulting in a Dividend Yield of 2,41%. The total shareholder return was 34,65%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Royalty Pharma (RPRX)?

Investing in stocks of Royalty Pharma (RPRX) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Royalty Pharma (RPRX) yield today?

The yield of Royalty Pharma (RPRX) was -0,47% in the last month, 34,65% in the last year and -9,13% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,87 in dividends, um Dividend Yield de 2,41%.If you wanted to buy 100 stocks of Royalty Pharma (RPRX) today, the total investment would be US$ 3.601,00, based on the current price of US$ 36,01.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 4.848,75In 5 years: US$ 3.272,23In 10 years: 3.601,00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Royalty Pharma PLC

Price

US$ 36,01

variation (12m)

34,65%

p/l

30,17

p/vp

1,61

DIVIDEND YIELD

2,41%

price RPRX

BVMF

RPRX

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of RPRX

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-0,47%

3 months

1,08%

1 year

34,65%

2 years

40,73%

5 years

-9,13%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

-0,47%

3 months

0,71%

1 year

28,74%

2 years

28,45%

5 years

-32,85%

10 years

0,00%

Indicators RPRX

check out the fundamentals of Royalty Pharma shares

P/E

30,17

Sector: -6.394,95 Industry: 11,45

P/SALES RATIO (PSR)

6,59

Sector: 1,18 Industry: 2,90

P/BV

1,61

Sector: -3.277,65 Industry: 1,04

DIVIDEND YIELD (DY)

2,41%

Sector: 0,42% Industry: 2,53%

ROA

2,77%

Sector: -7,03% Industry: 0,89%

ROE

5,33%

Sector: -1.483,67% Industry: 8,79%

ROIC

4,85%

Sector: -10,24% Industry: -

NET MARGIN

21,86%

Sector: -1,08% Industry: 24,73%

GROSS MARGIN

100,00%

Sector: -0,65% Industry: 1,54%

OPERATING MARGIN

56,71%

Sector: -6,32% Industry: 0,16%

P/EBITDA

12,56

Sector: -10.237,96 Industry: -0,58

P/EBIT

12,56

Sector: -10.043,61 Industry: -55,33

P/ASSET

0,83

Sector: 0,13 Industry: 0,11

BVPS

22,41

Sector: -1.418,99 Industry: 26,07

EPS

1,20

Sector: -1.404,67 Industry: 2,28

EQUITY / ASSETS

0,52

Sector: -0,01 Industry: 0,10

CAGR REVENUES 5 YEARS

1,43%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

-15,75%

Sector: - Industry: -

FAIR PRICE OF Royalty Pharma ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 36,01

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-31,69%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

RPRX indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JPM	14,68	2,41	16,42%	1,69%	US$ 860,49 B	32,96%
NU	31,00	7,72	24,89%	0,00%	US$ 73,89 B	25,41%
BAC	13,57	1,28	9,44%	2,09%	US$ 383,90 B	26,78%
MA	37,53	66,85	178,11%	0,51%	US$ 526,34 B	45,23%
HSBC	13,15	1,24	9,47%	4,65%	US$ 248,78 B	27,40%
BRK-B	21,94	1,61	7,32%	0,00%	US$ 1,08 T	12,82%
BRK-A	15,29	1,12	7,32%	0,00%	US$ 749,90 B	12,82%
RY	14,99	2,09	13,92%	2,86%	US$ 206,77 B	29,73%
C	12,80	0,85	6,62%	2,33%	US$ 181,41 B	17,06%
BLK	28,09	3,49	12,41%	1,79%	US$ 179,91 B	29,69%
ING	11,68	1,34	11,49%	5,18%	US$ 77,65 B	26,68%
PYPL	13,61	3,32	24,40%	0,00%	US$ 67,10 B	15,06%
PAGS	7,28	1,06	14,56%	2,78%	US$ 2,79 B	11,26%
XP	11,54	2,47	21,42%	3,46%	US$ 9,92 B	67,51%
BBVA	9,74	1,64	16,81%	3,99%	US$ 115,04 B	29,06%
WFC	12,44	1,43	11,46%	2,05%	US$ 260,81 B	25,59%
AXP	21,90	7,13	32,57%	0,92%	US$ 230,51 B	15,06%
LYG	11,44	1,08	9,47%	3,68%	US$ 68,91 B	23,07%
BCS	7,92	0,72	9,08%	2,07%	US$ 74,51 B	25,03%

comparison of RPRX with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History RPRX

current DY: 2,41%

5-year average DY: 2,20%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	15/08/2025	10/09/2025	0,22000000
Dividends	16/05/2025	10/06/2025	0,22000000
Dividends	21/02/2025	10/03/2025	0,22000000
Dividends	15/11/2024	10/12/2024	0,21000000
Dividends	16/08/2024	13/09/2024	0,21000000
Dividends	17/05/2024	14/06/2024	0,21000000
Dividends	16/02/2024	15/03/2024	0,21000000
Dividends	17/11/2023	15/12/2023	0,20000000
Dividends	18/08/2023	15/09/2023	0,20000000
Dividends	19/05/2023	15/06/2023	0,20000000
Dividends	16/02/2023	15/03/2023	0,20000000
Dividends	18/11/2022	15/12/2022	0,19000000
Dividends	19/08/2022	15/09/2022	0,19000000
Dividends	20/05/2022	15/06/2022	0,19000000
Dividends	18/02/2022	15/03/2022	0,19000000
Dividends	19/11/2021	15/12/2021	0,17000000
Dividends	20/08/2021	15/09/2021	0,17000000
Dividends	20/05/2021	15/06/2021	0,17000000
Dividends	19/02/2021	15/03/2021	0,17000000
Dividends	20/11/2020	15/12/2020	0,15000000
Dividends	15/09/2020	30/09/2020	0,15000000

ABOUT THE COMPANY Royalty Pharma

Royalty Pharma PLC

Average user rating I10

4.0 (1 people)

Estados Unidos

5 years

Foundation: 2020

2020

Year of debut on the stock exchange - 5 years

-

Employees

The Company Royalty Pharma PLC (Estados Unidos), is listed on Nasdaq with a market value of $ 15,29 Billions, having a net worth of $ 9,50 Billions.

The Company is listedthe in the sector of Financial and categorized in industry of Auxiliary Activities of Financial Services.

In the last 12 months the Company had a revenue of $ 2,32 Billions, which generated a profit in the amount of $ 506,92 Milhões.

As for its main indicators, the Company has a P/E ratio of 30,17, a P/BV ratio of 1,61 and in the last 12 months the dividend yield of RPRX was at 2,41%.

The Company is traded internationally through the ticker RPRX.

Market value

US$ 15,29 Billions

Net worth

US$ 9,50 Billions

US$ 9.502.940.000,00

Assets

US$ 18,32 Billions

US$ 18.323.000.000,00

Total Number of Shares

424,00 Milhões

424.000.000

Average Daily Trading Volume

US$ 4,28 Milhões

US$ 4.284.474,54

Sector

Financial

Industry

Auxiliary Activities of Financial Services

RPRX

RPRX revenue and profits

RPRX results

DRAG THE FRAME TO SEE MORE DATA

RPRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BRK-A - Berkshire Hathaway

US$ 734.180,00 7,18% (12M)

P/L

15,29

0,00%

ROE

7,32%

P/VP

1,12

BRK-B - Berkshire Hathaway

US$ 489,13 6,28% (12M)

P/L

21,94

0,00%

ROE

7,32%

P/VP

1,61

JPM - JPMorgan

US$ 300,89 39,00% (12M)

P/L

14,68

1,69%

ROE

16,42%

P/VP

2,41

SNEX - StoneX Group

US$ 95,83 63,59% (12M)

P/L

16,75

0,00%

ROE

14,33%

P/VP

2,40

BAC - Bank of America

US$ 48,65 18,70% (12M)

P/L

13,57

2,09%

ROE

9,44%

P/VP

1,28

PGR - Progressive

US$ 240,00 --3,62% (12M)

P/L

12,77

1,99%

ROE

34,58%

P/VP

4,42

C - Citigroup

US$ 93,93 46,72% (12M)

P/L

12,80

2,33%

ROE

6,62%

P/VP

0,85

WFC - Wells Fargo

US$ 77,62 30,10% (12M)

P/L

12,44

2,05%

ROE

11,46%

P/VP

1,43

BRK-A - Berkshire Hathaway

US$ 734.180,00 7,18% (12 M)

P/L

15,29

0,00%

ROE

7,32%

P/VP

1,12

BRK-B - Berkshire Hathaway

US$ 489,13 6,28% (12 M)

P/L

21,94

0,00%

ROE

7,32%

P/VP

1,61

JPM - JPMorgan

US$ 300,89 39,00% (12 M)

P/L

14,68

1,69%

ROE

16,42%

P/VP

2,41

SNEX - StoneX Group

US$ 95,83 63,59% (12 M)

P/L

16,75

0,00%

ROE

14,33%

P/VP

2,40

BAC - Bank of America

US$ 48,65 18,70% (12 M)

P/L

13,57

2,09%

ROE

9,44%

P/VP

1,28

PGR - Progressive

US$ 240,00 --3,62% (12 M)

P/L

12,77

1,99%

ROE

34,58%

P/VP

4,42

C - Citigroup

US$ 93,93 46,72% (12 M)

P/L

12,80

2,33%

ROE

6,62%

P/VP

0,85

WFC - Wells Fargo

US$ 77,62 30,10% (12 M)

P/L

12,44

2,05%

ROE

11,46%

P/VP

1,43

Frequently Asked Questions

What is the price of Royalty Pharma (RPRX) today?

The price of Royalty Pharma (RPRX) today is US$ 36,01, with a variation of 34.65% compared to the last year. The price of Royalty Pharma (RPRX) started the year trading around US$ 25,51 and today it is at US$ 36,01. Follow the real-time price chart, the historical price of Royalty Pharma (RPRX), and stock data from Ibovespa and international markets.

When does Royalty Pharma (RPRX) pay dividends?

Royalty Pharma (RPRX) distributed dividends in the last year,in the months of March, June and September totaling US$ 0,66. The Dividend Yield for the last 12 months is 2,41%.

Royalty Pharma (RPRX) is it worth it?

Currently, Royalty Pharma (RPRX) is priced at US$ 36,01, with a P/E of 30,17%, representing a deviation of 17,90% from its historical average P/E. In the last year, the stock showed a variation of 34.65% in its price and distributed US$ 0,66 in dividends, resulting in a Dividend Yield of 2,41%. The total shareholder return was 34,65%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Royalty Pharma (RPRX)?

Investing in stocks of Royalty Pharma (RPRX) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Royalty Pharma (RPRX) yield today?

The yield of Royalty Pharma (RPRX) was -0,47% in the last month, 34,65% in the last year and -9,13% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,87 in dividends, um Dividend Yield de 2,41%.

If you wanted to buy 100 stocks of Royalty Pharma (RPRX) today, the total investment would be US$ 3.601,00, based on the current price of US$ 36,01.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 4.848,75
In 5 years: US$ 3.272,23
In 10 years: 3.601,00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

RPRX

Royalty Pharma PLC

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of RPRX

check out the fundamentals of Royalty Pharma shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 2,41%

5-year average DY: 2,20%

type

date with

payment date

value

ABOUT THE COMPANY Royalty Pharma

Royalty Pharma PLC

Estados Unidos

5 years

2020

-

PROFIT X PRICE RPRX

RPRX results

RPRX cash flow

evolution of assets - RPRX

RPRX balance sheet

BRK-A - Berkshire Hathaway

BRK-B - Berkshire Hathaway

JPM - JPMorgan

SNEX - StoneX Group

BAC - Bank of America

PGR - Progressive

C - Citigroup

WFC - Wells Fargo

BRK-A - Berkshire Hathaway

BRK-B - Berkshire Hathaway

JPM - JPMorgan

SNEX - StoneX Group

BAC - Bank of America

PGR - Progressive

C - Citigroup

WFC - Wells Fargo

Frequently Asked Questions